Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Trading Update

21 Jan 2009 07:00

RNS Number : 9838L
ABCAM Plc
21 January 2009
 



For immediate release

2January 2009

ABCAM PLC

( "Abcam" or "the Company" )

Trading Update

Cambridge UK21 January 2009: Abcam plc, the rapidly growing bioscience company that markets antibodies via its own online catalogue, is pleased to report that trading for the six months to 31 December 2008 has been strong. A major feature of the period has been the continued weakness of sterling, which made a significant contribution to increasing our reported sales and gross margins.

Whilst the underlying business continues to grow in line with market expectations, the Board now believes that, in view of the above, reported profits for the full year are likely to be materially ahead of market expectations.

The Board remains confident in the prospects for continued growth, tempered only by an appreciation that even though the Company should be reasonably resilient to any downturn the threat of global recession remains a risk for every business.

The Company will report its interim results for the six months ended 31 December 2008 ithe week commencing 9 March 2009.

 

For further information please contact:

Abcam

+ 44 (0) 1223 696000

Jonathan Milner, Chief Executive Officer

Jeffrey Iliffe, Chief Financial Officer

www.abcam.com

Numis Securities

+ 44 (0) 20 7260 1000

Michael Meade / Nick Westlake - Nominated Adviser

James Black - Corporate Broking

Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Mary-Jane Johnson / Stasa Filiplic

`

Notes for editors 

 

About Abcam plc 

 

Abcam is a producer and distributor of research-grade antibodies headquartered in CambridgeUK, with a US office located in CambridgeMassachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 47,000 products, most of which are antibodies, from over 250 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs over 200 staff in its three operating companies. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEMSMFSUSEFF
Date   Source Headline
2nd Jul 20089:10 amRNSShareholding
7th May 20083:31 pmRNSGrant of Share Options
1st May 20087:01 amRNSTrading Update
29th Apr 20085:08 pmRNSShareholding
2nd Apr 20087:01 amRNSDirector's Dealings
26th Mar 200812:08 pmRNSShareholding
20th Mar 20083:35 pmRNSTransfer of Shares
17th Mar 200812:08 pmRNSShareholding
14th Mar 200812:02 pmRNSDirectors' Dealings
10th Mar 20087:02 amRNSInterim Results
15th Feb 20083:33 pmRNSShareholding
13th Feb 20087:00 amRNSShareholding
12th Feb 20087:00 amRNSNotification of Results
10th Dec 200712:55 pmRNSShareholding
7th Dec 20078:00 amRNSAnnual Report and Accounts
6th Dec 20079:29 amRNSDirector's Dealings
4th Dec 20074:14 pmRNSBlocklisting
28th Nov 20074:58 pmRNSShareholding
27th Nov 20077:01 amRNSShareholding
23rd Nov 20072:44 pmRNSShareholding
23rd Nov 20077:01 amRNSAdditional Listing
12th Nov 20077:01 amRNSLaboratory Collaboration
8th Nov 20074:18 pmRNSResult of AGM
7th Nov 20077:01 amRNSCFO Appointment
25th Oct 20077:01 amRNSShareholding
24th Oct 200712:17 pmRNSShareholding
23rd Oct 20074:37 pmRNSShareholding
23rd Oct 20073:50 pmRNSAdditional Listing
19th Oct 200711:21 amRNSExercise of Share Options
18th Oct 200712:21 pmRNSDirectors' Dealings
17th Oct 200712:38 pmRNSShareholding
16th Oct 20077:01 amRNSSecures Further Antibodies
11th Oct 200712:31 pmRNSShareholding
11th Oct 200712:30 pmRNSShareholding
1st Oct 20077:02 amRNSPreliminary Results
24th Sep 200711:06 amRNSNotice of Results
20th Sep 200710:08 amRNSEPT Disclosure
19th Sep 20077:02 amRNSRe Offer Discussions
17th Sep 20079:53 amRNSEPT Disclosure
13th Sep 200711:57 amRNSRule 8.3- Abcam
13th Sep 20079:59 amRNSEPT Disclosure
12th Sep 200711:58 amRNSRule 8.3- Abcam
11th Sep 20079:38 amRNSEPT Disclosure
10th Sep 200710:19 amRNSEPT Disclosure
31st Aug 20072:28 pmPRNRule 8.3 - Abcam plc
31st Aug 200712:02 pmRNSRule 8.3- Abcam
31st Aug 200710:27 amRNSEPT Disclosure
31st Aug 200710:08 amRNSRule 8.3-Abcam Plc
30th Aug 200712:24 pmRNSRule 8.3- Abcam plc
30th Aug 20079:43 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.